Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Glioblastoma 5Astrocytoma 5Neuroectodermal Tumors, Primitive 3Neurocytoma 2Brain Neoplasms 2Oligodendroglioma 1Lymphoma, Non-Hodgkin 1Gliosarcoma 1Glioma 1Ganglioglioma 1Craniopharyngioma 1

Interventions

Exenatide 3Temozolomide 2Surgical Procedures, Operative 2Mental Status and Dementia Tests 2Donepezil 2tozuleristide 1temsirolimus 1entinostat 1carboxyamido-triazole 1antineoplaston AS 2-1 1antineoplaston A10 1Thalidomide 1Surveys and Questionnaires 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Image-Guided 1Radiotherapy, Conformal 1Radiation 1Psychiatric Rehabilitation 1Photochemotherapy 1Pharmacogenomic Testing 1Paclitaxel 1Oxytocin 1Memantine 1Medication Errors 1Irinotecan 1Ginkgo biloba extract 1Fentanyl 1Docetaxel 1Dihematoporphyrin Ether 1Diazoxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Craniopharyngioma × antineoplaston AS 2-1 × Clear all
NCT00003458 2022-03-07

Antineoplaston Therapy in Treating Children With Brain Tumors

Burzynski Research Institute

Phase 2 Completed
34 enrolled 6 charts
CNSSarcoma

Astrocytoma, Craniopharyngioma, Glioblastoma, Oligodendroglioma, Neuroectodermal Tumors, Primitive, Ganglioglioma, Neurocytoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡